# Ibutamoren

Ibutamoren has 13 registered human trials. It is marketed for 4 different uses.

**In short**

- 13 registered human trials exist for Ibutamoren.
- Ibutamoren is not FDA-approved for any use.
- What has actually been studied: chronic kidney disease, kidney disease, growth hormone deficiency (ghd).
- Last checked against ClinicalTrials.gov on 2026-07-27.

## What it is sold for

- Muscle growth
- Sleep quality
- Appetite
- Anti-aging

## What has actually been tested

- Chronic Kidney Disease
- Kidney Disease
- Growth Hormone Deficiency (GHD)
- Growth Hormone Deficiency
- Aging
- Alzheimer's Disease
- NAFLD
- Nonalcoholic Fatty Liver
- NASH - Nonalcoholic Steatohepatitis
- Fibromyalgia
- Hip Fracture
- End Stage Renal Disease

## Every trial on record

| Trial ID | Title | Condition | Phase | Status | Enrolled |
|---|---|---|---|---|---|
| [NCT01343641](https://clinicaltrials.gov/study/NCT01343641) | Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects | Chronic Kidney Disease, Kidney Disease | Phase 2 | WITHDRAWN | 0 |
| [NCT06948214](https://clinicaltrials.gov/study/NCT06948214) | Phase 3 Study of LUM-201 in Children With Growth Hormone Deficiency | Growth Hormone Deficiency (GHD) | Phase 3 | RECRUITING | 150 |
| [NCT04614337](https://clinicaltrials.gov/study/NCT04614337) | Phase 2 Study of LUM-201 in Children With Growth Hormone Deficiency (OraGrowtH210 Trial) | Growth Hormone Deficiency | Phase 2 | COMPLETED | 104 |
| [NCT00474279](https://clinicaltrials.gov/study/NCT00474279) | Effects of an Oral GH Secretagogue (MK-677) on Body Composition and Functional Ability of Older Adults | Aging | Phase 2 | COMPLETED | 72 |
| [NCT00074529](https://clinicaltrials.gov/study/NCT00074529) | Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED) | Alzheimer's Disease | Phase 2 | COMPLETED | 512 |
| [NCT05364684](https://clinicaltrials.gov/study/NCT05364684) | The Impact of Ibutamoren on Nonalcoholic Fatty Liver Disease | NAFLD, Nonalcoholic Fatty Liver | Phase 2 | COMPLETED | 12 |
| [NCT05796440](https://clinicaltrials.gov/study/NCT05796440) | A Long-Term Safety Trial of LUM-201 in Children With Idiopathic Growth Hormone Deficiency Who Have Previously Completed a LUM-201 Clinical Trial (OraGrowtH211) | Growth Hormone Deficiency | Phase 2 | ENROLLING_BY_INVITATION | 60 |
| [NCT05250063](https://clinicaltrials.gov/study/NCT05250063) | Phase 2 Study of LUM-201 in Children Who Have Previously Completed the LUM-201-01 Trial (OraGrowtH213) | Growth Hormone Deficiency | Phase 2 | COMPLETED | 15 |
| [NCT07129759](https://clinicaltrials.gov/study/NCT07129759) | Phase 3 Long Term Safety Extension Study of LUM-201 in Children With Growth Hormone Deficiency | Growth Hormone Deficiency (GHD) | Phase 3 | NOT_YET_RECRUITING | 150 |
| [NCT00116129](https://clinicaltrials.gov/study/NCT00116129) | Efficacy and Safety of an Oral Growth Hormone Drug in the Treatment of Fibromyalgia | Fibromyalgia | Phase 2 | COMPLETED | 64 |
| [NCT00128115](https://clinicaltrials.gov/study/NCT00128115) | Treatment of Sarcopenia in Post-Hip Fracture Patients (0677-032) | Hip Fracture | Phase 2 | TERMINATED | 83 |
| [NCT04806854](https://clinicaltrials.gov/study/NCT04806854) | PK and PD Study of LUM-201 in Children With Idiopathic Growth Hormone Deficiency: (OraGrowtH212) | Growth Hormone Deficiency | Phase 2 | ACTIVE_NOT_RECRUITING | 24 |
| [NCT00395291](https://clinicaltrials.gov/study/NCT00395291) | Growth Hormone Secretagogue MK-0677 Effect on IGF-1 Levels in ESRD Patients | Chronic Kidney Disease, End Stage Renal Disease | Not phased | COMPLETED | 49 |

## Common questions

**How many human trials does Ibutamoren have?**
13, each listed above with a link to its original record.

**Is Ibutamoren FDA approved?**
No. It is not approved by the FDA for any indication.

**Where does this data come from?**
ClinicalTrials.gov. We count interventional human studies only. Every trial
links to its original record.

---

*Automated aggregation from public registries. Not medical advice. No physician
has reviewed this page. Source: https://www.whatsactuallyknown.com/compounds/ibutamoren*